Literature DB >> 6706226

KLE: a cell line with defective estrogen receptor derived from undifferentiated endometrial cancer.

G S Richardson, G R Dickersin, L Atkins, D T MacLaughlin, S Raam, L P Merk, F M Bradley.   

Abstract

KLE is a cell line derived from a poorly differentiated endometrial carcinoma that is aneuploid with chromosome numbers ranging from 51 to 66 and 6-8 marker chromosomes demonstrated by G banding. Tumors harvested from five of five nude mice bearing an inoculum for more than a month resemble the original specimen, and electron microscopy shows microvilli, many junctional processes, glycogenation, and a prominent nucleolonema. The cell cytosol contains a specific binder for estradiol, but there is no estrogen receptor in the nucleus and in a study reported elsewhere (Raam et al., Breast Cancer Res. Treat. 2, 277 (1982) ) translocation to the nucleus fails to occur. The enzyme phenotype of this cell is human, non-HeLa.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6706226     DOI: 10.1016/0090-8258(84)90080-5

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  18 in total

1.  Comparative biological properties of a recombinant chimeric anti-carcinoma mAb and a recombinant aglycosylated variant.

Authors:  P H Hand; B Calvo; D Milenic; T Yokota; M Finch; P Snoy; K Garmestani; O Gansow; J Schlom; S V Kashmiri
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

2.  DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination.

Authors:  Christopher Korch; Monique A Spillman; Twila A Jackson; Britta M Jacobsen; Susan K Murphy; Bruce A Lessey; V Craig Jordan; Andrew P Bradford
Journal:  Gynecol Oncol       Date:  2012-06-16       Impact factor: 5.482

3.  A polarized human endometrial cell line that binds and transports polymeric IgA.

Authors:  J M Ball; Z Moldoveanu; L R Melsen; P A Kozlowski; S Jackson; M J Mulligan; J F Mestecky; R W Compans
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-03       Impact factor: 2.416

4.  Dichloroacetate induces apoptosis in endometrial cancer cells.

Authors:  Jason Y Y Wong; Gordon S Huggins; Marcella Debidda; Nikhil C Munshi; Immaculata De Vivo
Journal:  Gynecol Oncol       Date:  2008-04-18       Impact factor: 5.482

5.  Sublethal damage repair after fractionated irradiation in endometrial cancer cell lines tested with the 96-well plate clonogenic assay.

Authors:  V Rantanen; S Grénman; J Kulmala; K Alanen; T Lakkala; R Grénman
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

6.  17Beta-estradiol suppresses TLR3-induced cytokine and chemokine production in endometrial epithelial cells.

Authors:  Margaret J Lesmeister; Rebecca L Jorgenson; Steven L Young; Michael L Misfeldt
Journal:  Reprod Biol Endocrinol       Date:  2005-12-29       Impact factor: 5.211

7.  Inactivating Mutations of the IK Gene Weaken Ku80/Ku70-Mediated DNA Repair and Sensitize Endometrial Cancer to Chemotherapy.

Authors:  Chao Gao; Guangxu Jin; Elizabeth Forbes; Lingegowda S Mangala; Yingmei Wang; Cristian Rodriguez-Aguayo; Paola Amero; Emine Bayraktar; Ye Yan; Gabriel Lopez-Berestein; Russell R Broaddus; Anil K Sood; Fengxia Xue; Wei Zhang
Journal:  Cancers (Basel)       Date:  2021-05-20       Impact factor: 6.639

8.  Comparative evaluation of cisplatin and carboplatin sensitivity in endometrial adenocarcinoma cell lines.

Authors:  V Rantanen; S Grénman; J Kulmala; R Grénman
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

9.  Characterization of EN-1078D, a poorly differentiated human endometrial carcinoma cell line: a novel tool to study endometrial invasion in vitro.

Authors:  Marie-Claude Dery; Celine Van Themsche; Diane Provencher; Anne-Marie Mes-Masson; Eric Asselin
Journal:  Reprod Biol Endocrinol       Date:  2007-09-25       Impact factor: 5.211

10.  Genomic characterization of five commonly used endometrial cancer cell lines.

Authors:  Eric J Devor; Jesus Gonzalez-Bosquet; Kristina W Thiel; Kimberly K Leslie
Journal:  Int J Oncol       Date:  2020-10-21       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.